IMAI Medtech | News, Hiring, Layoffs, Competitors, CEO, Fundraising Insights

---

IMAI Medtech is a pioneering company focused on revolutionizing oncology diagnostics through its innovative 3D histology technology. The company specializes in rapid and automated tissue preparation, enabling early and accurate cancer diagnosis, which enhances therapeutic outcomes and improves patient care. IMAI's solutions aim to eliminate the limitations of traditional 2D histology by providing complete quantification of biopsies and supporting pathologists with advanced digital imaging and algorithms.

🛍️ IMAI Medtech Product and Pricing News →

👔 IMAI Medtech CEO, Management and Leadership Team →

⚔️ IMAI Medtech Alternatives and Competitors →

💼 IMAI Medtech Hiring and Layoffs →

🤖 IMAI Medtech Developer, Integration and Automation News →

📈 IMAI Medtech Financials, Fundraising and Valuation News →

---

🛍️ IMAI Medtech Product and Pricing News

• IMAI Medtech is launching a clinical validation study comparing 3D and 2D cancer diagnostics using advanced 3D histology automation and machine learning.
• Francesca Catto, CEO of IMAI Medtech, pitched at the Bluelion Incubator event on November 29.
• IMAI Medtech, co-founded by Francesca Catto, is developing a robotic platform for 3D histopathology to improve cancer diagnosis.

---

👔 IMAI Medtech CEO, Management and Leadership Team

---

⚔️ IMAI Medtech Alternatives and Competitors

• Pictor Labs
|
• BioImagene
|
• CloudWave
|
• ClearDATA
|
• BookZurman
|
• Nexoya
|
• Flicron
|
• Daione

---

💼 IMAI Medtech Hiring and Layoffs

---

🤖 IMAI Medtech Developer, Integration and Automation News

---

📈 IMAI Medtech Financials, Fundraising and Valuation News

---

People also viewed

• Gallup
|
• Culture Amp
|
• Perspective
|
• Workleap
|
• 15Five
|
• People Insight